NASDAQ: RNLX - Renalytix Plc

Yield per half year: -43.83%
Sector: Healthcare

Renalytix Plc

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.72 -100% -21.62 -100%
P/S 16.65 33.75 -50.66%
P/BV -4.85 4.82 -200.75%
P/FCF 0 61 -100%
Ev/Ebitda -1.47 -22.17 -93.36%
Ev/S 18.34 22.56 -18.71%
Ev/FCF -1.39 68.75 -102.03%
E/P 0 0.0178 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-1246 4.98 -25135.52% -1722.31 -27.66%
ROE -631.25 9.61 -6667.55%
ROA -133.59 0.3443 -38903.94%
ROIC 0 7.63 -100%
ROS -1461.6 -25.17 5706.89%
ROCE 819.9 15.35 5241.24%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.2993 -3.68 -91.86% -0.228 +31.27%
Nеt Debt/Ebitda -0.1352 -3.44 -96.07%
Debt/Ratio 1.07 0.1985 439.4%
Debt/Equity 7.2 1.66 332.94%
Debt/Net Income -0.2551 10.32 -102.47%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5473 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 1.07 -100%
Average percentage for 5 years 0 0.498 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.5473

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
7/10
52.6 -56.89 -192.46%
Growth impulse Ebitda in 5 years 156.95 -54.68 -387.03%
Growth impulse Net Income in 5 years 259.74 -58.33 -545.29%
Growth impulse FCF in 5 years 164.17 -49.48 -431.79%
Growth impulse EPS in 5 years -1.23 -32.41 -96.2%
IP Score
4.03/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription